Agent for reducing side effects of kinase inhibitor
AssigneesAjinomoto Co., Inc., Yamaguchi University
InventorsNaoki YAMAMOTO, Isao SAKAIDA
Life of this patent
Estimating the term…
Abstract
The present invention relates to an agent for reducing the side effects of kinase inhibitors, the agent containing at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof as an active ingredient, and also relates to an anticancer medicine containing at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof, and a kinase inhibitor.
Claims18
An agent for reducing a side effect of a kinase inhibitor, the agent comprising at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof as an active ingredient.
An anticancer medicine, comprising a combination of:
- at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof, and
- a kinase inhibitor.
A medical kit comprising:
- at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof, and
- a kinase inhibitor.
Dependencies are inferred from the claim text.